Phathom Pharmaceuticals Inc

Predicción y previsión de precio de Phathom Pharmaceuticals Inc (PHAT)

$5.740

-1.040 (-18.12%)Al cierre

Predicciones de precio

1-Day Price Prediction
-3.27%
1-Week Prediction
-0.38%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

Ábrelo en la app para desbloquear previsiones a más largo plazo.

Loading chart…

Predicción y previsión de PHAT por análisis de gráficos similares

Alphio's PHAT stock price prediction model matches the current Phathom Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.55 (-3.27%). The 1-week path is $5.72 (-0.38%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

¿Debería comprar acciones de Phathom Pharmaceuticals Inc?

Phathom Pharmaceuticals (PHAT) is not a good buy right now due to its current price of $5.74, which is significantly below the average analyst price target of $20-$22. The stock has experienced a 63.46% year-to-date decline and a 17.05% drop over the last five days, indicating a bearish trend. Additionally, the RSI is at a low 19.803, suggesting oversold conditions, but the overall financial performance remains concerning with a gross margin of 79.68% in Q2 2026, while the company still faces challenges with a net income loss of $17.58 million in the same quarter. The primary risk is the ongoing legal challenge against the FDA, which could further impact market confidence.

PHAT cerró en $5.74 el Friday, tras bajar -18.12%

Phathom Pharmaceuticals Inc (PHAT) last closed at $5.74, losing -18.12%. These facts feed the 1-day and 1-week PHAT price prediction above.

Factores de la previsión

Los factores de la previsión de Phathom Pharmaceuticals Inc (PHAT) combinan patrones gráficos similares, estacionalidad y medias móviles.

Similar patterns

Positive

Bullish

Seasonality

Positive

Bullish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

Patrones gráficos similares

Acciones cuya trayectoria reciente más se parece a la de PHAT, ordenadas por similitud.

Análisis de estacionalidad de PHAT

Historically the probability of a positive October return for PHAT is 73.02%. November offers the highest probability of a positive month at 79.49%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

Proyecciones de precio a 10 años de PHAT

MesPrecio mínimoPrecio medioPrecio máximoROI potencial
Oct 2026$9.29$11.46$11.86+99.67%
Nov 2026$6.46$8.88$10.54+54.64%
Dec 2026$8.43$9.73$11.97+69.46%

En 2026, se proyecta que Phathom Pharmaceuticals Inc (PHAT) oscile entre $6.46 y $11.97.

Previsión mensual de Phathom Pharmaceuticals Inc para 2026

Previsión de PHAT para Oct de 2026
ROI potencial: 99.67%

En Oct de 2026, se proyecta que Phathom Pharmaceuticals Inc promedie $11.46, con un mínimo de $9.29 y un máximo de $11.86.

Previsión de PHAT para Nov de 2026
ROI potencial: 54.64%

En Nov de 2026, se proyecta que Phathom Pharmaceuticals Inc promedie $8.88, con un mínimo de $6.46 y un máximo de $10.54.

Previsión de PHAT para Dec de 2026
ROI potencial: 69.46%

En Dec de 2026, se proyecta que Phathom Pharmaceuticals Inc promedie $9.73, con un mínimo de $8.43 y un máximo de $11.97.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar